Fluorine-18-Fluorodeoxyglucose PET/CT Proved Valvular Endocarditis in a Native Valve Patient

Cureus. 2023 Nov 5;15(11):e48315. doi: 10.7759/cureus.48315. eCollection 2023 Nov.

Abstract

A 79-year-old woman with a background history of hypertension, diabetes mellitus, hypercholesterolemia, alcoholic liver disease, and osteoporosis presented to the hospital with fever and confusion. Based on the initial investigations, it was challenging to identify the primary source of infection. Positive group G streptococcus on blood cultures raised the suspicion of uncommon infective endocarditis (IE). Two transthoracic echocardiographic studies were performed a week apart, and both were inconclusive. She was also diagnosed with atrial fibrillation, and the decision for anticoagulation became difficult as the clinical suspicion for IE was very high. Fluorine-18-fluorodeoxyglucose (18F-FDG) PET/CT confirmed the diagnosis of native valve endocarditis (NVE), and the possible complication related to anticoagulation was prevented. Though 18F-FDG PET/CT is commonly used to evaluate prosthetic valve endocarditis (PVE) and IE related to cardiac devices and catheters, its role and applicability to evaluate challenging cases of NVE could be entertained.

Keywords: 18f-fdg pet ct in endocarditis; 18f-fdg pet ct to diagnose infective endocarditis; 18f-fdg pet/ct; anticoagulation in infective endocarditis; atypical infective endocarditis; mitral endocarditis; native valve endocarditis; pet-ct with 18f-fdg; transesophageal echocardiography in infective endocarditis.

Publication types

  • Case Reports